Drugs in use in schools for severely subnormal children.
This paper provides a review of the drug therapy used in the management of the severely subnormal child at school following the introduction of the 1970 Education Act.
Biomedical subjects
Publications and source records attributed to E May.
This paper provides a review of the drug therapy used in the management of the severely subnormal child at school following the introduction of the 1970 Education Act.
A major involvement of the immune system and of microbial flora in the HLA-B27 transgenic rat model of spondylarthropathy was demonstrated. The role of inflammatory pathways, such as cytokines and inducible nitric oxide synthase (iNOS) was investigated. Treatment with IL-10 failed to improve established disease, whereas such improvement was achieved with IL-11. In contrast, aggravation was observed after treatment with selective inhibitor of iNOS.
Explore the source record for details and available documents.